In its fiscal Q4 2025, which ended Jan. 31, financial performance was robust. Total revenue rose 20% year over year to $548.4 ...

VOQUEZNA® (vonoprazan) generated $55.3 million in 2024 net revenues in its first full year of launch, driven by strong demand, including $29.7 ...

KVH Industries, Inc., (Nasdaq: KVHI), reported financial results for the quarter and full year ended December 31, 2024 today. The company will hold ...

Limited ('Dingdong' or the 'Company') (NYSE: DDL), a leading fresh grocery e-commerce company in China, with advanced supply chain capabilities, today announced its unaudited financial results for the ...